This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Alzheimer's drug THA shows no lasting benefit in study
A Boston based study finds the experimental Alzheimer's treatment tetrahydrominoacridine THA fails to deliver lasting clinical benefits. Initial small improvements faded in a later trial phase though some family members reported temporary speech and daily task gains. Warner Lambert plans an FDA filing for Cognex.
MENTIONED IN THIS ARTICLE
Boston
Serge Gauthier
McGill University
Montreal
New England Journal of Medicine
British Medical Journal
R. Levy
Institute of Psychiatry
London
THA
Warner-Lambert
Barry Cohen
U.S. Food and Drug Administration
Cognex